AFP
DMTK

Ausdal Financial Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Ausdal Financial Partners’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,912
Closed -$800K – 521
2021
Q3 		$800K Buy
+24,912
New +$875K 0.12% 205

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ausdal Financial Partners's DMTK Position: Q4 2021 in Review

Ausdal Financial Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 24,912 shares — an estimated $800K sold.

Ausdal Financial Partners first reported a position in DMTK in Q3 2021 and held it in 1 quarter. The position peaked at $800K in Q3 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Ausdal Financial Partners reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ausdal Financial Partners sold 24,912 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $800K.
  • Ausdal Financial Partners first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Ausdal Financial Partners's DermTech, Inc. Common Stock position peaked at $800K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Ausdal Financial Partners's 13F filing for Q4 2021, filed 8 Feb 2022.